PTAB challenges

Proceedings overview

There is one AIA trial proceeding on file for US patent 10274325, which resulted in a discretionary denial of institution. This means that while the patent has been challenged, no claims have been invalidated or sustained by the PTAB in an instituted trial. From a defensive posture, the patent has survived an initial IPR challenge at the institution stage, potentially making future IPR-based defenses harder for the same or privy parties.

IPR2025-01602 — Avidbots Corporation et al. v. Brain Corp

• Type: Inter Partes Review
• Filed: 2025-12-04
• Status: Discretionary Denial – The petition was denied institution on procedural grounds, meaning the PTAB chose not to proceed with a full trial.
• Judge panel: [Information not publicly available in initial search results without accessing the full denial decision.]
• Petition grounds: [Information not publicly available in initial search results without accessing the full denial decision, but typically would include challenges under 35 U.S.C. §§ 102 and/or 103 against specific claims using identified prior art.]
• Institution decision: Denied on 2026-05-07. The Board issued an order of discretionary denial, indicating that a trial was not instituted. The specific reasoning for the procedural denial would be detailed in the official denial decision.
• Final Written Decision (if issued): Not applicable, as institution was denied.
• Settlement / termination: The proceeding terminated with a discretionary denial of institution.
• Appeal: Not applicable, as institution was denied.
• Defensive value: The patent owner, Brain Corp, successfully fended off an IPR challenge at the institution stage. This means no claims of US10274325 were considered for invalidation by the PTAB in a trial. A defendant currently facing assertion of this patent will find an IPR-based defense more challenging, especially if the grounds are similar to those raised by Avidbots Corporation et al., due to potential estoppel.

Strategic summary

Currently, all claims of US patent 10274325 remain UNTESTED at the merits stage of an AIA trial. No claims have been canceled or sustained by a Final Written Decision, as the sole IPR proceeding (IPR2025-01602) was denied institution. This indicates that the patent has not been narrowed through PTAB review.

Regarding the estoppel landscape, 35 U.S.C. § 315(e)(2) generally bars the petitioner (Avidbots Corporation et al.) and their privies from asserting in a civil action or another USPTO proceeding that a claim is invalid on any ground that the petitioner raised or reasonably could have raised during the IPR. For a new defendant being asserted against, prior-art grounds that are distinct from those presented in IPR2025-01602 (and not reasonably discoverable by Avidbots) would still be available for a new IPR petition or litigation defense. However, the discretionary denial itself might indicate a weak petition or a strategic decision by the Board, which could influence future petitions.

There are no clear pattern signals of aggressive PTAB appeals by the patent owner or multiple IPRs from the same petitioner based on the single proceeding. Unified Patents is noted as having filed the IPR, indicating a defensive aggregator's involvement.

Recommended next steps

• Since IPR2025-01602 resulted in a discretionary denial, there is no Final Written Decision to link to for claim invalidation. The patent remains active, and all claims are currently maintained.
• For any defendant considering challenging US10274325, it would be crucial to thoroughly analyze the PTAB's Order Denying Institution for IPR2025-01602 to understand the specific reasons for the discretionary denial. This analysis would inform whether similar or different prior art and arguments could overcome the procedural hurdles encountered by Avidbots Corporation et al.
• The absence of an instituted PTAB trial means the patent has not been "hardened" by surviving a full review. This could be an opportunity for a new petitioner with strong prior art and a well-crafted petition to challenge the claims.
• Monitor any further developments related to IPR2025-01602, particularly if the denial decision is appealed, which could provide additional insight into the Board's reasoning.

: https://portal.unifiedpatents.com/ptab/case/IPR2025-01602